{"ticker": {"uuid": "ebc374af-f110-4556-9f61-3e092b2c4c12", "symbol": "DXCM", "name": "DexCom Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "How Health Canada\u2019s Longer-Wear CGM Approval At DexCom (DXCM) Has Changed Its Investment Story", "summary": "Health Canada recently approved DexCom's G7 15 Day Continuous Glucose Monitoring System, extending sensor wear to 15.5 days with high accuracy. This approval is expected to reinforce DexCom's market position in Canada by enhancing convenience and digital health integration, thoug", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/how-health-canadas-longer-wear-cgm-approval-at-dexcom-dxcm-h", "source_name": "Simply Wall Street", "published_at": "2026-07-16T00:43:31", "published_display": "16 Jul 2026 00:43", "sentiment": "positive", "sentiment_pct": 64, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Inc. stock underperforms Wednesday when compared to competitors", "summary": "Shares of DexCom Inc. (DXCM) fell by 1.88% to $72.73 on Wednesday, despite a positive trading session for the broader stock market, with both the S&P 500 and Dow Jones Industrial Average seeing gains. This marked the second consecutive day of losses for the company's stock.", "url": "https://www.marketwatch.com/data-news/dexcom-inc-stock-underperforms-wednesday-when-compared-to-competitors-2c769ec2-3a447e60d36b?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-15T20:39:06", "published_display": "15 Jul 2026 20:39", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DXCM Company (NASDAQ: DXCM) shareholder to sell 1,700 shares", "summary": "Michael Brown plans to sell 1,700 shares of DXCM common stock through Morgan Stanley Smith Barney LLC Executive Financial Services around July 15, 2026, valued at $126,514.00. This planned sale follows two previous sales by Brown of 1,700 shares each in May and June 2026. The sha", "url": "https://www.stocktitan.net/sec-filings/DXCM/144-dexcom-inc-sec-filing-de1f1af543d8.html", "source_name": "Stock Titan", "published_at": "2026-07-15T20:05:11", "published_display": "15 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mizuho Adjusts Price Target on DexCom to $90 From $85, Maintains Outperform Rating", "summary": "Mizuho analysts have increased their price target for DexCom (DXCM) to $90 from $85, while reiterating an Outperform rating on the stock. This adjustment reflects continued confidence in the medical equipment company, which specializes in continuous glucose monitoring systems. Th", "url": "https://www.marketscreener.com/news/mizuho-adjusts-price-target-on-dexcom-to-90-from-85-maintains-outperform-rating-ce7f5ed2db8ff12c", "source_name": "marketscreener.com", "published_at": "2026-07-15T15:07:48", "published_display": "15 Jul 2026 15:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Inc. stock outperforms competitors despite losses on the day", "summary": "Shares of DexCom Inc. (DXCM) decreased by 2.92% to $74.12 on Tuesday, despite an overall positive trading session for the stock market, with the S&P 500 Index and Dow Jones Industrial Average both rising. This fall ended a two-day winning streak for the company's stock.", "url": "https://www.marketwatch.com/data-news/dexcom-inc-stock-outperforms-competitors-despite-losses-on-the-day-5b71ae54-d25e92f68fa3?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-14T21:07:54", "published_display": "14 Jul 2026 21:07", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "DexCom (DXCM) Revenue Breakdown - Main Composition", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwNBVV95cUxNV2ZWQnF6MTZUZ3ZFUXdlTlpoZjRySEIxcnc1X2tyTnI3b29PZ2FSZFdJNFFWUEJlNENmS1NGbW1mYjcxNEVCWUlvb245YWpwZ0cxZVQtVHVldW4wNmZaX1NDcUxaWjlLR2ZvWmJ4cG9PNDFHdGd3eDlCZDEyTURacmZ4dVprRFVkdk9hRnl5RXpad0hOcDBMMEVZdFNEYUtJQk9peWx4U3VTR3VTQlB1Mm9qNGNVSjVBeXJ4RWc3dklYcUMtTlpJbVVuSG1kZTFLanhiRVdLSkd5bXJDOENIZlplOUJVajdsemM3Ylk0Z1ZWWDFsOV9FSjZyRGRVeXBQd1VhbHI1N1FkMDh4U014RklQenVXMXdzLXc3TFNWaTFEOU9oTVZWMGVzbG5IMkx4RDlXZEVrdzJodEZGbzBTQ1lfZXdVdENjbVVSTHFfaDJKc1NvcHpMOHA2bFU2ckJmQk9sVHhVd184dm4zSXhaTlpLdjh0dTBkR1RQMUpTZzFaOWc0T2RUbUdnbmJFMDQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-14T15:19:50+00:00", "published_display": "14 Jul 2026 15:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DXCM Secures Health Canada Authorization for Dexcom G7 15 Day CGM", "summary": "DexCom (DXCM) has received Health Canada authorization for its Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for adults with diabetes, marking a significant regulatory milestone. This system offers real-time glucose readings for up to 15.5 days, aiming for simpler a", "url": "https://www.theglobeandmail.com/investing/markets/stocks/ISRG-Q/pressreleases/3277269/dxcm-secures-health-canada-authorization-for-dexcom-g7-15-day-cgm/", "source_name": "The Globe and Mail", "published_at": "2026-07-14T15:38:45", "published_display": "14 Jul 2026 15:38", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom receives Health Canada authorization for G7 15 Day CGM By Investing.com", "summary": "Dexcom Inc. has received Health Canada authorization for its G7 15 Day Continuous Glucose Monitoring System for adults with diabetes. The system offers extended wear, waterproof sensors, and direct connectivity to Apple Watch, with additional features for tracking and sharing glu", "url": "https://ng.investing.com/news/stock-market-news/dexcom-receives-health-canada-authorization-for-g7-15-day-cgm-93CH-2597601", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T04:38:08", "published_display": "14 Jul 2026 04:38", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom (DXCM) Gains Health Canada Approval for New CGM System", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPRHVtQnlWa2tnTGZLRl9iY3BMZHZLZGxOWWZvQ1QzNHBVaXhYblBJdHd2TjV5OE9yeVc3RjljbHpfSW55Z0syampXV2h5a2pXejRtWGJFN0hRelY4SzY0U0Z1ME5vMC13QlYtQW5JX093NWdmRTgtZkl5WTNyRERNRG5jYXNMMm5WdXhsM3lFRVdZMlBRU2Nxbkk5SXE1Q2ZFOHNQM2lEeHV2V09BVWtUcmcyT0VrMVR5TjlvelQ5VzJYM2I4RVJRenVRRW1EOV8zTlJ1Wg?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-13T22:33:33+00:00", "published_display": "13 Jul 2026 22:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom's G7 Glucose Monitor Receives Health Canada Authorization for Adults With Diabetes", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/dexcom-apos-g7-glucose-monitor-210508237.html", "source_name": "MT Newswires", "published_at": "2026-07-13T21:05:08+00:00", "published_display": "13 Jul 2026 21:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New 15.5\u2011day Dexcom glucose sensor authorized in Canada for adults", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcTQ4ODJuRG1BRjJKM3VZMmZLbmlUTXRXV1JZZ09NMXFWZ2t3SFZyWC1hb1dsVS1yQUcyTkljenRMUlh0RnE5WTlNdzdPVl9iTWhEenh6UXI3UWRmWFR0VHNiMGlWeWNhM1hVdUpWNmF5RGZFVm9UNUNDWDE0cjduVFZuaXhLUUR1S2hNUUF0UjBYaU9TNW94b1dCTnA2SW1ONjBDSGdlXzVDUURDeGRsWkFXTENqRkNSVnhTNXpXc1U?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T20:45:00+00:00", "published_display": "13 Jul 2026 20:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LE DEXCOM G7 15 JOURS A OBTENU L\u2019AUTORISATION DE SANT\u00c9 CANADA : UNE DUR\u00c9E DE PORT PROLONG\u00c9E ET UNE CONTINUIT\u00c9 AM\u00c9LIOR\u00c9E POUR LES ADULTES CANADIENS VIVANT AVEC LE DIAB\u00c8TE", "summary": "Dexcom, Inc. has announced that Health Canada has authorized its Dexcom G7 15-day continuous glucose monitoring (CGM) system for adults aged 18 and over living with diabetes. This system offers the longest wear duration for a Health Canada-approved CGM and is designed for ease of", "url": "https://www.joplinglobe.com/region/national_business/le-dexcom-g7-15-jours-a-obtenu-l-autorisation-de-sant-canada-une-dur-e/article_6cb21238-992f-5f5c-9aae-8f98bae81dab.html", "source_name": "The Joplin Globe", "published_at": "2026-07-13T21:08:04", "published_display": "13 Jul 2026 21:08", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom receives Health Canada authorization for G7 15 Day CGM", "summary": "Dexcom Inc. has received Health Canada authorization for its G7 15 Day Continuous Glucose Monitoring System for adults with diabetes. The system offers real-time glucose readings, waterproof sensors, and direct connectivity features such as Apple Watch integration and Dexcom Clar", "url": "https://m.uk.investing.com/news/stock-market-news/dexcom-receives-health-canada-authorization-for-g7-15-day-cgm-93CH-4768527?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-13T21:07:52", "published_display": "13 Jul 2026 21:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes", "summary": "Dexcom, Inc. has announced that Health Canada has authorized its Dexcom G7 15 Day Continuous Glucose Monitoring System for Canadian adults with diabetes. This system offers the longest wear time and highest accuracy among Health Canada-authorized CGM systems, providing real-time ", "url": "https://finance.yahoo.com/healthcare/articles/dexcom-g7-15-day-receives-204500816.html", "source_name": "Market source", "published_at": "2026-07-13T21:07:48", "published_display": "13 Jul 2026 21:07", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Inc. stock outperforms competitors on strong trading day", "summary": "DexCom Inc. (DXCM) saw its stock rise by 1.85% to $76.35 on Monday, outperforming the broader market as both the S&P 500 Index and Dow Jones Industrial Average fell. This marks the second consecutive day of gains for the company's stock despite a weak trading session.", "url": "https://www.marketwatch.com/data-news/dexcom-inc-stock-outperforms-competitors-on-strong-trading-day-c5153bf7-dadd3fee110d?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-13T21:07:43", "published_display": "13 Jul 2026 21:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DEXCOM,-INC.", "summary": "Dexcom G7 15 Day has received authorization from Health Canada. The continuous glucose monitoring system is compatible with smart devices, which are sold separately. Further compatibility information is available on Dexcom's website.", "url": "https://thefacts.com/ap_news/dexcom--inc/image_dadaf466-ccd8-5942-8732-f4518c948864.html", "source_name": "The Facts", "published_at": "2026-07-13T20:46:43", "published_display": "13 Jul 2026 20:46", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's why you should retain DexCom stock in your portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOWGJOTkN6TGc0ZmRyNG42NzBhSDJlbEZ5aERvTU1FOXFCdjZmOG9LZEEtQjZ5NVdvQWhnSGJrcnpvTVd1SndobzJWNHNtbnR4YndnbTk1Rlg1Q0hYTkdGZmszREpsWmp0U0dOZ3EtVUROSHgtWE1RTTRCcXZVeXNxZk1ta3pNQTlZZWJ3UEdUZ0VtQTRmUGVRRTJya1VyVDlyX0Zsei1JZHpRcUlIa3JOeUpBTlhQQTZTNXE0OG9ia01DOVQ4MUhZOUt3?oc=5", "source_name": "MSN", "published_at": "2026-07-13T17:07:57+00:00", "published_display": "13 Jul 2026 17:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guarantor: JPMorgan Chase & Co.", "summary": "This document is a pricing supplement for structured investments offered by JPMorgan Chase Financial Company LLC, guaranteed by JPMorgan Chase & Co. These auto callable contingent interest notes are linked to the common stock of DexCom, Inc. and are designed for investors seeking", "url": "https://www.streetinsider.com/SEC+Filings/Form+424B2+JPMORGAN+CHASE+%26amp%3B+CO/26759273.html", "source_name": "StreetInsider", "published_at": "2026-07-13T10:08:22", "published_display": "13 Jul 2026 10:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is DexCom stock underperforming the Dow?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOSWcwVV9XckJDWEZQZGEyTWtZUFFCU3J4bXVXMFNXNXZWVXpSb1FSNnpwUm1hUV8yeEZWU2ZpcXdiY0NQNlZiQUJyTm1yTU1JNXpnRE9hME9pQkpYbG9wZHdXV3l6aDk2dnlCZkd0VEFjVlA0VTJIYnczamkyOF9HcnJqNjFBbjI4T2J6ZjBOdjlJeFlGTElfaXNyeUM1M0pILU1sZlo0UURoU0QwejdreA?oc=5", "source_name": "MSN", "published_at": "2026-07-12T21:03:55+00:00", "published_display": "12 Jul 2026 21:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DEXCOM INC (NASDAQ:DXCM) Screens as a Strong Growth Stock with Favorable Technical Setup", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQTnBRYnJpTWczdVpkeUFsMl84dTd6eDhBRmJFaklVaHdLaDB3c0t0R2lZdlRadWZEbDkxWk1pdmxDMU5vdTB0Tll0Y3VXSS1XUGxfNlNJMXJlY3lheHZfaXo5Wm9vZ2pzdU1SZ0xneUdjcWRJQWhoOFMxa1p4NGk4bWUxNy00LVp6UjJkVThlUFdkWGJ1NmdaT1UzOXhpbzNuUWlHamRVbHNSV29vcnV5X3lMMUFnTEJCekx0UGZ6SG9GTDJTV3E5VzhyZ1poaVU5b3FN?oc=5", "source_name": "ChartMill", "published_at": "2026-07-11T10:10:35+00:00", "published_display": "11 Jul 2026 10:10", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is DexCom (DXCM) Undervalued Following Its Investor Day Sentiment Shift?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNVk9VOWktdE9reHZhLXEwN2xfY2RKd21DQjRyUnFIbzJVOFVpOURZVERfb0F5eFlsQ2J2WkF6YkxtRGRIcFJubXZDN25BWWx5Y3R3RFhiMlhhQURuSXBGY3BUd0swMmRIS3pDXy1pa29DOFdZTG1tclZ2Y3g4TllYR3hOTzc4S083dUJHTmRZN0VCT1BvYlRLWGV0UmZpTE5aQzdCTTlnQ19XWkE?oc=5", "source_name": "Market source", "published_at": "2026-07-10T23:13:10+00:00", "published_display": "10 Jul 2026 23:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Inc. stock underperforms Thursday when compared to competitors", "summary": "Shares of DexCom Inc. (DXCM) fell by 1.40% to $73.02 on Thursday, underperforming the broader market which saw the S&P 500 Index and Dow Jones Industrial Average rise. This decline ended a five-day winning streak for DexCom stock.", "url": "https://www.marketwatch.com/data-news/dexcom-inc-stock-underperforms-thursday-when-compared-to-competitors-3cdbe3a8-33829d4afc99?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-09T20:57:00", "published_display": "09 Jul 2026 20:57", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom slips as investors appear to pause ahead of earnings and product transition", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNWHV1eW9WdmdOalE0aHBoRVZsZjBjaEZpNHBRMUpCdmlHb0haUFZzaVZWT3U1LTBtWDFfWFNWV2lTTzA0c2FvTDdiYy02Sy1GUFpVMnd6UnhJTWRkeS03eTBkMjFrd29WMzRuZTNONHZxcXd6cVNUOFJCc201MkFsYmpnVWstQ2R4cXlveHRFRTZoRExNT1ZuMzQ4R2VSekI2SHJScE5SOWhLd0ZaU1RaTlFBRi1ydw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-09T17:34:00+00:00", "published_display": "09 Jul 2026 17:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is DexCom\u2019s (DXCM) Sensor Recall Exposing Deeper Questions About Its Quality Controls and Data Systems?", "summary": "DexCom (DXCM) has initiated a voluntary Class II recall of specific G7 continuous glucose monitoring sensor lots due to theft during destruction, leading to improper sterilization and potential inaccuracies. This incident, combined with previous app-related recalls, raises concer", "url": "https://www.sahmcapital.com/news/content/is-dexcoms-dxcm-sensor-recall-exposing-deeper-questions-about-its-quality-controls-and-data-systems-2026-07-08", "source_name": "Sahm", "published_at": "2026-07-09T17:07:31", "published_display": "09 Jul 2026 17:07", "sentiment": "negative", "sentiment_pct": 29, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors\u2019 Confidence in DexCom (DXCM) Rises as Growth Outlook Reassured", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxORXdsaWZSQk5xRjJoZzJwa0RJWjhrYXAySUwtRU5GVURIWlNxZ1RxS3hVSGhLNkE5WHotX0tTYWw4SUFqZE02SlpnRTY2dVBiaEFVSkRvYzU0VUljV2MyRlZXNW1GaEU0SGc2WWh6dzRXRzRsWnh3M0loa09pbENPWnRDU0k3V0h1Mm8tQk1wWEZHSFQwRzJiMnBLM0NFTEU5?oc=5", "source_name": "Market source", "published_at": "2026-07-09T15:15:19+00:00", "published_display": "09 Jul 2026 15:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom plans July 30 results and webcast at 4:30 p.m.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQVzFhTXBnUUNKU2pzWUhCMWZqaEdyb1ZvUXltd0d1OTdPTHlPbG9nZXZGdVVZaGJuWl90YURXUTdyNkRDRUFmYjZNMGJZNE1PYjhVUkJ3WmZKRVhKVDBpZHdlVTNqYmsyY3pzY3lSLThRaXNwWkZwcFBTby1BNDFRQ3lmWWpxTkM5TEZwcmJRY19IUFl1OXhsZ0dFbE8wcXp0VDZ4TzR5YTM2V0dsVUpFY3pBNER0NVI4dlV4YkVLc3c?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-09T12:30:00+00:00", "published_display": "09 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time", "summary": "DexCom, Inc. (NASDAQ:DXCM) announced it will release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. The company will host a conference call and webcast at 4:30 p.m. Eastern Time on the same day to discuss its performance. Details for acce", "url": "https://www.businesswire.com/news/home/20260709775369/en/Dexcom-Schedules-Second-Quarter-2026-Earnings-Release-and-Conference-Call-for-July-30-2026-at-430-p.m.-Eastern-Time", "source_name": "Business Wire", "published_at": "2026-07-09T12:31:35", "published_display": "09 Jul 2026 12:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 P.m. Eastern Time", "summary": "DexCom, Inc. (NASDAQ: DXCM) announced it will release its second quarter 2026 financial results on Thursday, July 30, 2026, after the market closes. The company will also host a conference call at 4:30 p.m. Eastern Time to discuss these results.", "url": "https://www.moomoo.com/news/post/72716987/press-release-dexcom-schedules-second-quarter-2026-earnings-release-and?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-09T12:25:52", "published_display": "09 Jul 2026 12:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom Inc. focuses on continuous glucose monitoring as investors track long-term growth", "summary": "Dexcom Inc. specializes in continuous glucose monitoring (CGM) systems for diabetes management, a key area for growth investors. The company's Nasdaq listing and focus on recurring revenue from sensor sales position it well in the expanding diabetes care market. Dexcom's G6 and G", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/dexcom-inc-focuses-on-continuous-glucose-monitoring-as-investors-track/69730500", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T10:07:37", "published_display": "09 Jul 2026 10:07", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why You Should Retain DexCom Stock in Your Portfolio for Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOSXNjTk80a2F3TEhrUVptTVRkX3JEQ2RpLUNmX3hpTGZGQnA5cTNVWldsV0FnbGZVUHU5S21kRFgzTXBYcF83Q1liOHZIb0lDQzc1RjJ4MXF0MjlxOW8tRkhNQlY2VHlwZG5YeVdhZjgtTWlMSWgzM3VhS1dlaldkS0RZYkZkN1dKamJrazF2UTZpWVQxc0NJcnNn?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom Inc. focuses on continuous glucose monitoring growth as a medical technology player", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQbTVvS0RkdHpJU2lsXzJjMnM0T0VucDZyZ1QwRmxSdlkzal9nc0FpcmkzY09sUEFtZ3cyWkdReW9yNmhKaE9DWXdESHVicUtVWk9NRTVCUlZGb2gtb2NBcHpBLTMyNDRLZWVHQUJLRGRweGxPS3NobTBRLUtOVU5NMjVEUzkzT3Rlc1c4dDVYZEJINDZLZHpHZjY1M2ZOa3E0alJubGVocGdyVk9NZkMyQXFZa3daQTRMYlpVaTdteFk1S1FuaXRqR1FB?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-04T06:36:23+00:00", "published_display": "04 Jul 2026 06:36", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom (DXCM) Stock After Three-Year 45% Slide Is The Market Too Pessimistic", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPMkxlMVBJeEdoWURiSV9WTWVQREZkODM4UkR4SVNaSllJaEc5R0RRdzFyTGNJZEJuLVVVQ012NW1pTmV0amRXMll0ZGxXOHZoc3F4d3prQTlFMlBVSERuZWhFaGw4RUJOcE5tSjRFQWhoVEdpLWFyQ0ZuSF8tTG5nRGVaNF9EQ0FZbG03ZXo3X1J5SnFuNHc?oc=5", "source_name": "Market source", "published_at": "2026-06-27T07:00:00+00:00", "published_display": "27 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piper Sandler Raises its Price Target on DexCom (DXCM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNdVMtTnk3cXlrdUY4eTdETWJmbFUzQzhFdHV6TGtZcUo2WjViVDQyMFcwQzBIT2pXWG5PMlpfTnQxXzJOV1B4eWw3RXZfS19xV0F0V3o1eWRUb0NlR21WTjAxbXkxVmZ6aWd5U0VrQ3czRS0tM3pGdUpxX2hfQjZxaFZ5QzZ3N2stWXhsTHo2N0F2YlhzVlhOaEZaSUd6UVk?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom Inc. Stock (US2521311074): Shares Slip After Recent Nasdaq Tech Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOVVJFOFdXU3BPRkNwLXd5Nzg4NDRWWFk0WDNZSWFHcHU3LWNUcGZQTndnTk9yZHhoMlNDLWI1NTVFN19uaWo1dVF1TzYtY1ctTjZfa0FCS0lhMnYwRFRsOE8wdUp0TVlWUVRXT1oyQW4yam0zVHVxeE13Z2hsN0hzM2RYNzdjN2RvUTcxRXdXSlZmRk85UjVTX19TVFg1akRUNnFPaU5SbHFyaHZ1SEF1QmVOeEJZcFJSZXY1S3U5NjJ6em8?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Is It Time To Reassess DexCom (DXCM) After Recent Glucose Monitoring Headlines?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom Inc. stock (US2521311074): shares edge lower after recent Nasdaq volatility", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX3AxV1RZbHVHdUNlYmx5VXRMV0x5T0ZfdFhRaEdPUHFhcDFlNG5YaGNLMlpncC1xbUpYRkVDSEd2eU1JU0Z0T1JLYzNoTm9xdFNvNVFsRTlhQmlyQ2JxbHZ6cjBhUjV2UW9QQU1ETExEOHNfS1B5QXZ3UHY1eGp1d3RGa21zdXhiSjNsVWNVQXptREx1WEZHZ2tNLWc2N1hyMWViWmp1VnVFSXdhWW8wdkFjb2g0ZGhtaVpZUUV3Q0paUHlq?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom Inc. stock (US2521311074): diabetes-tech player draws fresh fund flows and cautious optimism", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQM0pLUVd3cWZZTDlBMEhJdl9jczZ5MzhORzdqb2hKYk9RUW9hUUI0NVphdk9hM1o2UWhscEhYU3NQTVVNY0h3bDdLSTRXLVNuY0xnQ0RrNFpoZ21tbkRvRl84YzNBTW52Nk1BeU5FakdGMm9pR2h6bDF6NFpWaG16SUY2ZXZYOW1YQkZtQktpV1VraFh1XzdUSkVZMFRDTkstSDU2bExBeE9aYXNSMmFzVE81cTIzWGtEb09UcVNXdV9nQjRw?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Might Finally Be Cheap Enough (NASDAQ:DXCM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxORVhuWG91NDgtRDNMRGNZMl9rbUxoLXdQcWlXbHhKNkFYXzFuWnJVU2ZFcV9fUFFvLXB5RGFUa19WLXVNd0g3R01XMHNnWUZqbkZDZjY5SmxDM1lwUTZBNFBtVVV2YzNGVnFpVXJnTXJYQy1OTmp3WG9HVTVCQXZJUHNvVQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Dexcom stock (US2521311074): Insider sale adds focus on shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQTEtGczl4OHFfNU1rNDZqX1JZQVdpYXBWTzJaZ3hlZ0lyWXpLSTVyMnNxQUJ5bTZhSU81azI3bkFqdVpEN2dxcEtTbWhsLTRDSUJQQXpkeG9MeEVVR2pRUGU2MVl4UGlNRkdKWEd2LVlvQ05hczdoT1IzaG9aZjhRNlJQT2FUTG9sOWRqSTZscG9xYVEzVkl6RlNRUWQzLWZMWDZLaExkRjlUVjNyZG9tWFBPRVVVT0pPaHc?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom stock (US2521311074): Analyst moves follow Elliott deal and new long-term targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNRGl1YnMzcWJaQnBIeEpQSTR5YWd5Sk9BTU5DclJfelk0Q0lsZ0hTczRjSWY2RUtBc29oaU1qQTUzdXNlSjJRNFd6bFFrXzVCUUhudWdIenFpUWFjbi1aVkktZkNDdHdtY285ZjFpcVZjNHU5VmxZVF9jNFh1RE1BY1pZS3NEWmlTYV9hQVpzMmNPSGF1U1R4c0lIZnZ5ZktObl9NSE9lU3d2ZEFRZDdyRndZeFhoNjBudWFLU1VCZ2FHZjNO?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Stock Jumps After Diabetes Management Firm Reaches Agreement With Elliott Investment Management", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNMnFBdEZWbEVNbDVPVFAwelM3Ykk1QkZoeVN4S1FNNmNWNm9ubWxNNXM0ZEtLVDRjazJTOGlxWkpLNk9Udy1VODdJeVEyemlMTzlFS29lblpwZm1oY3Fnb3NIQzdhaXk0Z1NjZEprSE4zWWpoY09iMjRvcVc1QmxpWEJyVXA0UjRjbkI1ZGZITnd4dXF4ejVldkM4V2tydm5aQlFuTmFUeFFsY2ZFdFVUUGhDMWpVRjdEVGxkSGhQbVIzVzY4a2hwUnY1MDRWR1Vf?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "DexCom (DXCM) Margin Improvement Challenges Cautious Narratives After Q1 2026 Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Stock Up on Q1 Earnings & Revenues Beat, Margins Rise", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZkt5cGxWMTd4LVItdzRjeGNsY0szLXVxNHRBYTNRalNOdG44QnN1cGt3SGVxRjVVYzFkWXIwd3RwSGtFUklsUk1MaV9NZWhIOE9NRzIyNTRyblhEMkhPTUlxT2JxV0t0VzJlQ1dzQ3R5dWNfTGt5X0pRWFF0YTJkQVJuSEFoM0h1SnpuRm51MGQ2R1hCZ1M5R1A3eTduWnFlWndjSDlmZ2FpUEx4OUxfaVhwMA?oc=5", "source_name": "TradingView", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom expands 15-day glucose monitor as quarterly sales reach $1.19B", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPT2RBUXk4eFlLNmk3djlscXFnUWxTWkpVQ3Zfd1J0eWJvYmVlZWw1S3prXzY0ZGxHYjM3U2FLTFhwVi1va2J2VGNnM0RudlNERkZ2NTdKYTUyakVOME9fcWYzcnB3ZjQyeUc5NmVUTmk3Y2NZYm1jRHhvdE5aaGpOMDRraG0zSWdiQ2NHM0dpeFIzcXdvQUtfX0NMUjFqTjQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Here's Why You Should Hold DexCom Stock in Your Portfolio for Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQZXg3dXZOT01ESFVOMzVmOVU0eHBseVJyb0dxX3AwRDdEZzJLMUJOa2QyUjl1X2M1a2tYYUl2SXlBN0lvT3dueTNPeGJlZUQxOHc0STJ2VUJrTGI4Q3JmQm9UNEY0UHZtcHlycVJlbVhDVHdybE80dm54M3BySzA3VTkzUGl4UWRaWkR0ME40czRRV0JDVjlSaWRoV2VPcWU2eExwUjNpT0Z0akprbFRnYW9KdUswRUJrMGVUUVB3?oc=5", "source_name": "TradingView", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "The Strong Earnings Posted By DexCom (NASDAQ:DXCM) Are A Good Indication Of The Strength Of The Business", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxOZDNJSzdtR3lVc05WY0VsV0VRN0MzdWIwVjBvbVN2TlY5dWpzVjZGVXA1a3U3cTA4cWxxTW54QmFBZTJVTDlvZV96RXRzbERQMXBwdklLbDNOdFNsWkFvT194d0tYWjBRaWFyNkpRYnRYdGpQSW1zekFMLXJvM2xTcm8ycEN6MWE3UHlodmhVTzY1X3NPU2wxbHBjby01MWxGX2FlSl9FOC1aODhPSjF3WjhlZXlxMjdGQlJwbmU0ZXdoSGd3Q0Z1X1FJTkNEYmRzWVE0S1hfY1otWVRKRkg3aVdqckF2blBob0JITDJrdjM?oc=5", "source_name": "Dexcom Investor Relations", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Beat: DexCom, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-02T07:00:00+00:00", "published_display": "02 Nov 2025 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inside Dexcom\u2019s strategy to stay ahead in the $13.6bn CGM market", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPSy1qZGRYRFY4ZFp4Ym9yOTBvdXdFN212UEd1aWJQSm1zRF8wallQSWQ5S3RkQjBrQk9PbC1CWXF2cF9hRVFHSUdMWURjTVVNRmNHNXVVOFVfNGtxUENKT2ZOTEhVblZRRy1iOGhzbWpBc2l0c2hLQl9kYU5XYThDMEkxV21ydkNXUWF4M0pfYUJWSk9jWEU4b0d1cDF6dGZwdjNMenhVX09URXo4?oc=5", "source_name": "Medical Device Network", "published_at": "2025-08-07T07:00:00+00:00", "published_display": "07 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "How Health Canada\u2019s Longer-Wear CGM Approval At DexCom (DXCM) Has Changed Its Investment Story", "summary": "Health Canada recently approved DexCom's G7 15 Day Continuous Glucose Monitoring System, extending sensor wear to 15.5 days with high accuracy. This approval is expected to reinforce DexCom's market position in Canada by enhancing convenience and digital health integration, thoug", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/how-health-canadas-longer-wear-cgm-approval-at-dexcom-dxcm-h", "source_name": "Simply Wall Street", "published_at": "2026-07-16T00:43:31", "published_display": "16 Jul 2026 00:43", "sentiment": "positive", "sentiment_pct": 64, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Inc. stock underperforms Wednesday when compared to competitors", "summary": "Shares of DexCom Inc. (DXCM) fell by 1.88% to $72.73 on Wednesday, despite a positive trading session for the broader stock market, with both the S&P 500 and Dow Jones Industrial Average seeing gains. This marked the second consecutive day of losses for the company's stock.", "url": "https://www.marketwatch.com/data-news/dexcom-inc-stock-underperforms-wednesday-when-compared-to-competitors-2c769ec2-3a447e60d36b?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-15T20:39:06", "published_display": "15 Jul 2026 20:39", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DXCM Company (NASDAQ: DXCM) shareholder to sell 1,700 shares", "summary": "Michael Brown plans to sell 1,700 shares of DXCM common stock through Morgan Stanley Smith Barney LLC Executive Financial Services around July 15, 2026, valued at $126,514.00. This planned sale follows two previous sales by Brown of 1,700 shares each in May and June 2026. The sha", "url": "https://www.stocktitan.net/sec-filings/DXCM/144-dexcom-inc-sec-filing-de1f1af543d8.html", "source_name": "Stock Titan", "published_at": "2026-07-15T20:05:11", "published_display": "15 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mizuho Adjusts Price Target on DexCom to $90 From $85, Maintains Outperform Rating", "summary": "Mizuho analysts have increased their price target for DexCom (DXCM) to $90 from $85, while reiterating an Outperform rating on the stock. This adjustment reflects continued confidence in the medical equipment company, which specializes in continuous glucose monitoring systems. Th", "url": "https://www.marketscreener.com/news/mizuho-adjusts-price-target-on-dexcom-to-90-from-85-maintains-outperform-rating-ce7f5ed2db8ff12c", "source_name": "marketscreener.com", "published_at": "2026-07-15T15:07:48", "published_display": "15 Jul 2026 15:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Inc. stock outperforms competitors despite losses on the day", "summary": "Shares of DexCom Inc. (DXCM) decreased by 2.92% to $74.12 on Tuesday, despite an overall positive trading session for the stock market, with the S&P 500 Index and Dow Jones Industrial Average both rising. This fall ended a two-day winning streak for the company's stock.", "url": "https://www.marketwatch.com/data-news/dexcom-inc-stock-outperforms-competitors-despite-losses-on-the-day-5b71ae54-d25e92f68fa3?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-14T21:07:54", "published_display": "14 Jul 2026 21:07", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom (DXCM) Revenue Breakdown - Main Composition", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwNBVV95cUxNV2ZWQnF6MTZUZ3ZFUXdlTlpoZjRySEIxcnc1X2tyTnI3b29PZ2FSZFdJNFFWUEJlNENmS1NGbW1mYjcxNEVCWUlvb245YWpwZ0cxZVQtVHVldW4wNmZaX1NDcUxaWjlLR2ZvWmJ4cG9PNDFHdGd3eDlCZDEyTURacmZ4dVprRFVkdk9hRnl5RXpad0hOcDBMMEVZdFNEYUtJQk9peWx4U3VTR3VTQlB1Mm9qNGNVSjVBeXJ4RWc3dklYcUMtTlpJbVVuSG1kZTFLanhiRVdLSkd5bXJDOENIZlplOUJVajdsemM3Ylk0Z1ZWWDFsOV9FSjZyRGRVeXBQd1VhbHI1N1FkMDh4U014RklQenVXMXdzLXc3TFNWaTFEOU9oTVZWMGVzbG5IMkx4RDlXZEVrdzJodEZGbzBTQ1lfZXdVdENjbVVSTHFfaDJKc1NvcHpMOHA2bFU2ckJmQk9sVHhVd184dm4zSXhaTlpLdjh0dTBkR1RQMUpTZzFaOWc0T2RUbUdnbmJFMDQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-14T15:19:50+00:00", "published_display": "14 Jul 2026 15:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DXCM Secures Health Canada Authorization for Dexcom G7 15 Day CGM", "summary": "DexCom (DXCM) has received Health Canada authorization for its Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for adults with diabetes, marking a significant regulatory milestone. This system offers real-time glucose readings for up to 15.5 days, aiming for simpler a", "url": "https://www.theglobeandmail.com/investing/markets/stocks/ISRG-Q/pressreleases/3277269/dxcm-secures-health-canada-authorization-for-dexcom-g7-15-day-cgm/", "source_name": "The Globe and Mail", "published_at": "2026-07-14T15:38:45", "published_display": "14 Jul 2026 15:38", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom receives Health Canada authorization for G7 15 Day CGM By Investing.com", "summary": "Dexcom Inc. has received Health Canada authorization for its G7 15 Day Continuous Glucose Monitoring System for adults with diabetes. The system offers extended wear, waterproof sensors, and direct connectivity to Apple Watch, with additional features for tracking and sharing glu", "url": "https://ng.investing.com/news/stock-market-news/dexcom-receives-health-canada-authorization-for-g7-15-day-cgm-93CH-2597601", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T04:38:08", "published_display": "14 Jul 2026 04:38", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom (DXCM) Gains Health Canada Approval for New CGM System", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPRHVtQnlWa2tnTGZLRl9iY3BMZHZLZGxOWWZvQ1QzNHBVaXhYblBJdHd2TjV5OE9yeVc3RjljbHpfSW55Z0syampXV2h5a2pXejRtWGJFN0hRelY4SzY0U0Z1ME5vMC13QlYtQW5JX093NWdmRTgtZkl5WTNyRERNRG5jYXNMMm5WdXhsM3lFRVdZMlBRU2Nxbkk5SXE1Q2ZFOHNQM2lEeHV2V09BVWtUcmcyT0VrMVR5TjlvelQ5VzJYM2I4RVJRenVRRW1EOV8zTlJ1Wg?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-13T22:33:33+00:00", "published_display": "13 Jul 2026 22:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom's G7 Glucose Monitor Receives Health Canada Authorization for Adults With Diabetes", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/dexcom-apos-g7-glucose-monitor-210508237.html", "source_name": "MT Newswires", "published_at": "2026-07-13T21:05:08+00:00", "published_display": "13 Jul 2026 21:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New 15.5\u2011day Dexcom glucose sensor authorized in Canada for adults", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcTQ4ODJuRG1BRjJKM3VZMmZLbmlUTXRXV1JZZ09NMXFWZ2t3SFZyWC1hb1dsVS1yQUcyTkljenRMUlh0RnE5WTlNdzdPVl9iTWhEenh6UXI3UWRmWFR0VHNiMGlWeWNhM1hVdUpWNmF5RGZFVm9UNUNDWDE0cjduVFZuaXhLUUR1S2hNUUF0UjBYaU9TNW94b1dCTnA2SW1ONjBDSGdlXzVDUURDeGRsWkFXTENqRkNSVnhTNXpXc1U?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T20:45:00+00:00", "published_display": "13 Jul 2026 20:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LE DEXCOM G7 15 JOURS A OBTENU L\u2019AUTORISATION DE SANT\u00c9 CANADA : UNE DUR\u00c9E DE PORT PROLONG\u00c9E ET UNE CONTINUIT\u00c9 AM\u00c9LIOR\u00c9E POUR LES ADULTES CANADIENS VIVANT AVEC LE DIAB\u00c8TE", "summary": "Dexcom, Inc. has announced that Health Canada has authorized its Dexcom G7 15-day continuous glucose monitoring (CGM) system for adults aged 18 and over living with diabetes. This system offers the longest wear duration for a Health Canada-approved CGM and is designed for ease of", "url": "https://www.joplinglobe.com/region/national_business/le-dexcom-g7-15-jours-a-obtenu-l-autorisation-de-sant-canada-une-dur-e/article_6cb21238-992f-5f5c-9aae-8f98bae81dab.html", "source_name": "The Joplin Globe", "published_at": "2026-07-13T21:08:04", "published_display": "13 Jul 2026 21:08", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom receives Health Canada authorization for G7 15 Day CGM", "summary": "Dexcom Inc. has received Health Canada authorization for its G7 15 Day Continuous Glucose Monitoring System for adults with diabetes. The system offers real-time glucose readings, waterproof sensors, and direct connectivity features such as Apple Watch integration and Dexcom Clar", "url": "https://m.uk.investing.com/news/stock-market-news/dexcom-receives-health-canada-authorization-for-g7-15-day-cgm-93CH-4768527?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-13T21:07:52", "published_display": "13 Jul 2026 21:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes", "summary": "Dexcom, Inc. has announced that Health Canada has authorized its Dexcom G7 15 Day Continuous Glucose Monitoring System for Canadian adults with diabetes. This system offers the longest wear time and highest accuracy among Health Canada-authorized CGM systems, providing real-time ", "url": "https://finance.yahoo.com/healthcare/articles/dexcom-g7-15-day-receives-204500816.html", "source_name": "Market source", "published_at": "2026-07-13T21:07:48", "published_display": "13 Jul 2026 21:07", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Inc. stock outperforms competitors on strong trading day", "summary": "DexCom Inc. (DXCM) saw its stock rise by 1.85% to $76.35 on Monday, outperforming the broader market as both the S&P 500 Index and Dow Jones Industrial Average fell. This marks the second consecutive day of gains for the company's stock despite a weak trading session.", "url": "https://www.marketwatch.com/data-news/dexcom-inc-stock-outperforms-competitors-on-strong-trading-day-c5153bf7-dadd3fee110d?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-13T21:07:43", "published_display": "13 Jul 2026 21:07", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DEXCOM,-INC.", "summary": "Dexcom G7 15 Day has received authorization from Health Canada. The continuous glucose monitoring system is compatible with smart devices, which are sold separately. Further compatibility information is available on Dexcom's website.", "url": "https://thefacts.com/ap_news/dexcom--inc/image_dadaf466-ccd8-5942-8732-f4518c948864.html", "source_name": "The Facts", "published_at": "2026-07-13T20:46:43", "published_display": "13 Jul 2026 20:46", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's why you should retain DexCom stock in your portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOWGJOTkN6TGc0ZmRyNG42NzBhSDJlbEZ5aERvTU1FOXFCdjZmOG9LZEEtQjZ5NVdvQWhnSGJrcnpvTVd1SndobzJWNHNtbnR4YndnbTk1Rlg1Q0hYTkdGZmszREpsWmp0U0dOZ3EtVUROSHgtWE1RTTRCcXZVeXNxZk1ta3pNQTlZZWJ3UEdUZ0VtQTRmUGVRRTJya1VyVDlyX0Zsei1JZHpRcUlIa3JOeUpBTlhQQTZTNXE0OG9ia01DOVQ4MUhZOUt3?oc=5", "source_name": "MSN", "published_at": "2026-07-13T17:07:57+00:00", "published_display": "13 Jul 2026 17:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guarantor: JPMorgan Chase & Co.", "summary": "This document is a pricing supplement for structured investments offered by JPMorgan Chase Financial Company LLC, guaranteed by JPMorgan Chase & Co. These auto callable contingent interest notes are linked to the common stock of DexCom, Inc. and are designed for investors seeking", "url": "https://www.streetinsider.com/SEC+Filings/Form+424B2+JPMORGAN+CHASE+%26amp%3B+CO/26759273.html", "source_name": "StreetInsider", "published_at": "2026-07-13T10:08:22", "published_display": "13 Jul 2026 10:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is DexCom stock underperforming the Dow?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOSWcwVV9XckJDWEZQZGEyTWtZUFFCU3J4bXVXMFNXNXZWVXpSb1FSNnpwUm1hUV8yeEZWU2ZpcXdiY0NQNlZiQUJyTm1yTU1JNXpnRE9hME9pQkpYbG9wZHdXV3l6aDk2dnlCZkd0VEFjVlA0VTJIYnczamkyOF9HcnJqNjFBbjI4T2J6ZjBOdjlJeFlGTElfaXNyeUM1M0pILU1sZlo0UURoU0QwejdreA?oc=5", "source_name": "MSN", "published_at": "2026-07-12T21:03:55+00:00", "published_display": "12 Jul 2026 21:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DEXCOM INC (NASDAQ:DXCM) Screens as a Strong Growth Stock with Favorable Technical Setup", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQTnBRYnJpTWczdVpkeUFsMl84dTd6eDhBRmJFaklVaHdLaDB3c0t0R2lZdlRadWZEbDkxWk1pdmxDMU5vdTB0Tll0Y3VXSS1XUGxfNlNJMXJlY3lheHZfaXo5Wm9vZ2pzdU1SZ0xneUdjcWRJQWhoOFMxa1p4NGk4bWUxNy00LVp6UjJkVThlUFdkWGJ1NmdaT1UzOXhpbzNuUWlHamRVbHNSV29vcnV5X3lMMUFnTEJCekx0UGZ6SG9GTDJTV3E5VzhyZ1poaVU5b3FN?oc=5", "source_name": "ChartMill", "published_at": "2026-07-11T10:10:35+00:00", "published_display": "11 Jul 2026 10:10", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is DexCom (DXCM) Undervalued Following Its Investor Day Sentiment Shift?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNVk9VOWktdE9reHZhLXEwN2xfY2RKd21DQjRyUnFIbzJVOFVpOURZVERfb0F5eFlsQ2J2WkF6YkxtRGRIcFJubXZDN25BWWx5Y3R3RFhiMlhhQURuSXBGY3BUd0swMmRIS3pDXy1pa29DOFdZTG1tclZ2Y3g4TllYR3hOTzc4S083dUJHTmRZN0VCT1BvYlRLWGV0UmZpTE5aQzdCTTlnQ19XWkE?oc=5", "source_name": "Market source", "published_at": "2026-07-10T23:13:10+00:00", "published_display": "10 Jul 2026 23:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Inc. stock underperforms Thursday when compared to competitors", "summary": "Shares of DexCom Inc. (DXCM) fell by 1.40% to $73.02 on Thursday, underperforming the broader market which saw the S&P 500 Index and Dow Jones Industrial Average rise. This decline ended a five-day winning streak for DexCom stock.", "url": "https://www.marketwatch.com/data-news/dexcom-inc-stock-underperforms-thursday-when-compared-to-competitors-3cdbe3a8-33829d4afc99?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-09T20:57:00", "published_display": "09 Jul 2026 20:57", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom slips as investors appear to pause ahead of earnings and product transition", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNWHV1eW9WdmdOalE0aHBoRVZsZjBjaEZpNHBRMUpCdmlHb0haUFZzaVZWT3U1LTBtWDFfWFNWV2lTTzA0c2FvTDdiYy02Sy1GUFpVMnd6UnhJTWRkeS03eTBkMjFrd29WMzRuZTNONHZxcXd6cVNUOFJCc201MkFsYmpnVWstQ2R4cXlveHRFRTZoRExNT1ZuMzQ4R2VSekI2SHJScE5SOWhLd0ZaU1RaTlFBRi1ydw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-09T17:34:00+00:00", "published_display": "09 Jul 2026 17:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is DexCom\u2019s (DXCM) Sensor Recall Exposing Deeper Questions About Its Quality Controls and Data Systems?", "summary": "DexCom (DXCM) has initiated a voluntary Class II recall of specific G7 continuous glucose monitoring sensor lots due to theft during destruction, leading to improper sterilization and potential inaccuracies. This incident, combined with previous app-related recalls, raises concer", "url": "https://www.sahmcapital.com/news/content/is-dexcoms-dxcm-sensor-recall-exposing-deeper-questions-about-its-quality-controls-and-data-systems-2026-07-08", "source_name": "Sahm", "published_at": "2026-07-09T17:07:31", "published_display": "09 Jul 2026 17:07", "sentiment": "negative", "sentiment_pct": 29, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors\u2019 Confidence in DexCom (DXCM) Rises as Growth Outlook Reassured", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxORXdsaWZSQk5xRjJoZzJwa0RJWjhrYXAySUwtRU5GVURIWlNxZ1RxS3hVSGhLNkE5WHotX0tTYWw4SUFqZE02SlpnRTY2dVBiaEFVSkRvYzU0VUljV2MyRlZXNW1GaEU0SGc2WWh6dzRXRzRsWnh3M0loa09pbENPWnRDU0k3V0h1Mm8tQk1wWEZHSFQwRzJiMnBLM0NFTEU5?oc=5", "source_name": "Market source", "published_at": "2026-07-09T15:15:19+00:00", "published_display": "09 Jul 2026 15:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom plans July 30 results and webcast at 4:30 p.m.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQVzFhTXBnUUNKU2pzWUhCMWZqaEdyb1ZvUXltd0d1OTdPTHlPbG9nZXZGdVVZaGJuWl90YURXUTdyNkRDRUFmYjZNMGJZNE1PYjhVUkJ3WmZKRVhKVDBpZHdlVTNqYmsyY3pzY3lSLThRaXNwWkZwcFBTby1BNDFRQ3lmWWpxTkM5TEZwcmJRY19IUFl1OXhsZ0dFbE8wcXp0VDZ4TzR5YTM2V0dsVUpFY3pBNER0NVI4dlV4YkVLc3c?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-09T12:30:00+00:00", "published_display": "09 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time", "summary": "DexCom, Inc. (NASDAQ:DXCM) announced it will release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. The company will host a conference call and webcast at 4:30 p.m. Eastern Time on the same day to discuss its performance. Details for acce", "url": "https://www.businesswire.com/news/home/20260709775369/en/Dexcom-Schedules-Second-Quarter-2026-Earnings-Release-and-Conference-Call-for-July-30-2026-at-430-p.m.-Eastern-Time", "source_name": "Business Wire", "published_at": "2026-07-09T12:31:35", "published_display": "09 Jul 2026 12:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 P.m. Eastern Time", "summary": "DexCom, Inc. (NASDAQ: DXCM) announced it will release its second quarter 2026 financial results on Thursday, July 30, 2026, after the market closes. The company will also host a conference call at 4:30 p.m. Eastern Time to discuss these results.", "url": "https://www.moomoo.com/news/post/72716987/press-release-dexcom-schedules-second-quarter-2026-earnings-release-and?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-09T12:25:52", "published_display": "09 Jul 2026 12:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom Inc. focuses on continuous glucose monitoring as investors track long-term growth", "summary": "Dexcom Inc. specializes in continuous glucose monitoring (CGM) systems for diabetes management, a key area for growth investors. The company's Nasdaq listing and focus on recurring revenue from sensor sales position it well in the expanding diabetes care market. Dexcom's G6 and G", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/dexcom-inc-focuses-on-continuous-glucose-monitoring-as-investors-track/69730500", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T10:07:37", "published_display": "09 Jul 2026 10:07", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why You Should Retain DexCom Stock in Your Portfolio for Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOSXNjTk80a2F3TEhrUVptTVRkX3JEQ2RpLUNmX3hpTGZGQnA5cTNVWldsV0FnbGZVUHU5S21kRFgzTXBYcF83Q1liOHZIb0lDQzc1RjJ4MXF0MjlxOW8tRkhNQlY2VHlwZG5YeVdhZjgtTWlMSWgzM3VhS1dlaldkS0RZYkZkN1dKamJrazF2UTZpWVQxc0NJcnNn?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom Inc. focuses on continuous glucose monitoring growth as a medical technology player", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQbTVvS0RkdHpJU2lsXzJjMnM0T0VucDZyZ1QwRmxSdlkzal9nc0FpcmkzY09sUEFtZ3cyWkdReW9yNmhKaE9DWXdESHVicUtVWk9NRTVCUlZGb2gtb2NBcHpBLTMyNDRLZWVHQUJLRGRweGxPS3NobTBRLUtOVU5NMjVEUzkzT3Rlc1c4dDVYZEJINDZLZHpHZjY1M2ZOa3E0alJubGVocGdyVk9NZkMyQXFZa3daQTRMYlpVaTdteFk1S1FuaXRqR1FB?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-04T06:36:23+00:00", "published_display": "04 Jul 2026 06:36", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom (DXCM) Stock After Three-Year 45% Slide Is The Market Too Pessimistic", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPMkxlMVBJeEdoWURiSV9WTWVQREZkODM4UkR4SVNaSllJaEc5R0RRdzFyTGNJZEJuLVVVQ012NW1pTmV0amRXMll0ZGxXOHZoc3F4d3prQTlFMlBVSERuZWhFaGw4RUJOcE5tSjRFQWhoVEdpLWFyQ0ZuSF8tTG5nRGVaNF9EQ0FZbG03ZXo3X1J5SnFuNHc?oc=5", "source_name": "Market source", "published_at": "2026-06-27T07:00:00+00:00", "published_display": "27 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piper Sandler Raises its Price Target on DexCom (DXCM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNdVMtTnk3cXlrdUY4eTdETWJmbFUzQzhFdHV6TGtZcUo2WjViVDQyMFcwQzBIT2pXWG5PMlpfTnQxXzJOV1B4eWw3RXZfS19xV0F0V3o1eWRUb0NlR21WTjAxbXkxVmZ6aWd5U0VrQ3czRS0tM3pGdUpxX2hfQjZxaFZ5QzZ3N2stWXhsTHo2N0F2YlhzVlhOaEZaSUd6UVk?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom Inc. Stock (US2521311074): Shares Slip After Recent Nasdaq Tech Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOVVJFOFdXU3BPRkNwLXd5Nzg4NDRWWFk0WDNZSWFHcHU3LWNUcGZQTndnTk9yZHhoMlNDLWI1NTVFN19uaWo1dVF1TzYtY1ctTjZfa0FCS0lhMnYwRFRsOE8wdUp0TVlWUVRXT1oyQW4yam0zVHVxeE13Z2hsN0hzM2RYNzdjN2RvUTcxRXdXSlZmRk85UjVTX19TVFg1akRUNnFPaU5SbHFyaHZ1SEF1QmVOeEJZcFJSZXY1S3U5NjJ6em8?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess DexCom (DXCM) After Recent Glucose Monitoring Headlines?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom Inc. stock (US2521311074): shares edge lower after recent Nasdaq volatility", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX3AxV1RZbHVHdUNlYmx5VXRMV0x5T0ZfdFhRaEdPUHFhcDFlNG5YaGNLMlpncC1xbUpYRkVDSEd2eU1JU0Z0T1JLYzNoTm9xdFNvNVFsRTlhQmlyQ2JxbHZ6cjBhUjV2UW9QQU1ETExEOHNfS1B5QXZ3UHY1eGp1d3RGa21zdXhiSjNsVWNVQXptREx1WEZHZ2tNLWc2N1hyMWViWmp1VnVFSXdhWW8wdkFjb2g0ZGhtaVpZUUV3Q0paUHlq?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom Inc. stock (US2521311074): diabetes-tech player draws fresh fund flows and cautious optimism", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQM0pLUVd3cWZZTDlBMEhJdl9jczZ5MzhORzdqb2hKYk9RUW9hUUI0NVphdk9hM1o2UWhscEhYU3NQTVVNY0h3bDdLSTRXLVNuY0xnQ0RrNFpoZ21tbkRvRl84YzNBTW52Nk1BeU5FakdGMm9pR2h6bDF6NFpWaG16SUY2ZXZYOW1YQkZtQktpV1VraFh1XzdUSkVZMFRDTkstSDU2bExBeE9aYXNSMmFzVE81cTIzWGtEb09UcVNXdV9nQjRw?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Might Finally Be Cheap Enough (NASDAQ:DXCM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxORVhuWG91NDgtRDNMRGNZMl9rbUxoLXdQcWlXbHhKNkFYXzFuWnJVU2ZFcV9fUFFvLXB5RGFUa19WLXVNd0g3R01XMHNnWUZqbkZDZjY5SmxDM1lwUTZBNFBtVVV2YzNGVnFpVXJnTXJYQy1OTmp3WG9HVTVCQXZJUHNvVQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom stock (US2521311074): Insider sale adds focus on shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQTEtGczl4OHFfNU1rNDZqX1JZQVdpYXBWTzJaZ3hlZ0lyWXpLSTVyMnNxQUJ5bTZhSU81azI3bkFqdVpEN2dxcEtTbWhsLTRDSUJQQXpkeG9MeEVVR2pRUGU2MVl4UGlNRkdKWEd2LVlvQ05hczdoT1IzaG9aZjhRNlJQT2FUTG9sOWRqSTZscG9xYVEzVkl6RlNRUWQzLWZMWDZLaExkRjlUVjNyZG9tWFBPRVVVT0pPaHc?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom stock (US2521311074): Analyst moves follow Elliott deal and new long-term targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNRGl1YnMzcWJaQnBIeEpQSTR5YWd5Sk9BTU5DclJfelk0Q0lsZ0hTczRjSWY2RUtBc29oaU1qQTUzdXNlSjJRNFd6bFFrXzVCUUhudWdIenFpUWFjbi1aVkktZkNDdHdtY285ZjFpcVZjNHU5VmxZVF9jNFh1RE1BY1pZS3NEWmlTYV9hQVpzMmNPSGF1U1R4c0lIZnZ5ZktObl9NSE9lU3d2ZEFRZDdyRndZeFhoNjBudWFLU1VCZ2FHZjNO?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Stock Jumps After Diabetes Management Firm Reaches Agreement With Elliott Investment Management", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNMnFBdEZWbEVNbDVPVFAwelM3Ykk1QkZoeVN4S1FNNmNWNm9ubWxNNXM0ZEtLVDRjazJTOGlxWkpLNk9Udy1VODdJeVEyemlMTzlFS29lblpwZm1oY3Fnb3NIQzdhaXk0Z1NjZEprSE4zWWpoY09iMjRvcVc1QmxpWEJyVXA0UjRjbkI1ZGZITnd4dXF4ejVldkM4V2tydm5aQlFuTmFUeFFsY2ZFdFVUUGhDMWpVRjdEVGxkSGhQbVIzVzY4a2hwUnY1MDRWR1Vf?oc=5", "source_name": "TIKR.com", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom (DXCM) Margin Improvement Challenges Cautious Narratives After Q1 2026 Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DexCom Stock Up on Q1 Earnings & Revenues Beat, Margins Rise", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZkt5cGxWMTd4LVItdzRjeGNsY0szLXVxNHRBYTNRalNOdG44QnN1cGt3SGVxRjVVYzFkWXIwd3RwSGtFUklsUk1MaV9NZWhIOE9NRzIyNTRyblhEMkhPTUlxT2JxV0t0VzJlQ1dzQ3R5dWNfTGt5X0pRWFF0YTJkQVJuSEFoM0h1SnpuRm51MGQ2R1hCZ1M5R1A3eTduWnFlWndjSDlmZ2FpUEx4OUxfaVhwMA?oc=5", "source_name": "TradingView", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom expands 15-day glucose monitor as quarterly sales reach $1.19B", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPT2RBUXk4eFlLNmk3djlscXFnUWxTWkpVQ3Zfd1J0eWJvYmVlZWw1S3prXzY0ZGxHYjM3U2FLTFhwVi1va2J2VGNnM0RudlNERkZ2NTdKYTUyakVOME9fcWYzcnB3ZjQyeUc5NmVUTmk3Y2NZYm1jRHhvdE5aaGpOMDRraG0zSWdiQ2NHM0dpeFIzcXdvQUtfX0NMUjFqTjQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why You Should Hold DexCom Stock in Your Portfolio for Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQZXg3dXZOT01ESFVOMzVmOVU0eHBseVJyb0dxX3AwRDdEZzJLMUJOa2QyUjl1X2M1a2tYYUl2SXlBN0lvT3dueTNPeGJlZUQxOHc0STJ2VUJrTGI4Q3JmQm9UNEY0UHZtcHlycVJlbVhDVHdybE80dm54M3BySzA3VTkzUGl4UWRaWkR0ME40czRRV0JDVjlSaWRoV2VPcWU2eExwUjNpT0Z0akprbFRnYW9KdUswRUJrMGVUUVB3?oc=5", "source_name": "TradingView", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Strong Earnings Posted By DexCom (NASDAQ:DXCM) Are A Good Indication Of The Strength Of The Business", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxOZDNJSzdtR3lVc05WY0VsV0VRN0MzdWIwVjBvbVN2TlY5dWpzVjZGVXA1a3U3cTA4cWxxTW54QmFBZTJVTDlvZV96RXRzbERQMXBwdklLbDNOdFNsWkFvT194d0tYWjBRaWFyNkpRYnRYdGpQSW1zekFMLXJvM2xTcm8ycEN6MWE3UHlodmhVTzY1X3NPU2wxbHBjby01MWxGX2FlSl9FOC1aODhPSjF3WjhlZXlxMjdGQlJwbmU0ZXdoSGd3Q0Z1X1FJTkNEYmRzWVE0S1hfY1otWVRKRkg3aVdqckF2blBob0JITDJrdjM?oc=5", "source_name": "Dexcom Investor Relations", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Beat: DexCom, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-02T07:00:00+00:00", "published_display": "02 Nov 2025 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inside Dexcom\u2019s strategy to stay ahead in the $13.6bn CGM market", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPSy1qZGRYRFY4ZFp4Ym9yOTBvdXdFN212UEd1aWJQSm1zRF8wallQSWQ5S3RkQjBrQk9PbC1CWXF2cF9hRVFHSUdMWURjTVVNRmNHNXVVOFVfNGtxUENKT2ZOTEhVblZRRy1iOGhzbWpBc2l0c2hLQl9kYU5XYThDMEkxV21ydkNXUWF4M0pfYUJWSk9jWEU4b0d1cDF6dGZwdjNMenhVX09URXo4?oc=5", "source_name": "Medical Device Network", "published_at": "2025-08-07T07:00:00+00:00", "published_display": "07 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 103, "total_relevant": 60, "sentiment_summary": {"positive": 19, "negative": 5, "neutral": 36, "score": 55, "total": 60, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 18.8, "count": 31}, {"event": "earnings", "label": "Earnings", "weight": 10.04, "count": 21}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 2.2, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 19, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 74.96, "latest_week": "2026-07-10", "one_week_move": 5.2, "four_week_move": -0.5, "twelve_week_move": 17.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.763623, "market_dynamics_buy_signal": false, "relative_strength": -7.73667, "fair_value_gap": -14.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 51.4224, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+5.2% over one week, -0.5% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 15}, {"label": "Ad Hoc News", "count": 6}, {"label": "MarketWatch", "count": 4}, {"label": "Stock Titan", "count": 4}, {"label": "simplywall.st", "count": 4}, {"label": "Moomoo", "count": 2}, {"label": "MSN", "count": 2}, {"label": "StockStory", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 49}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 31}, {"label": "Earnings", "count": 21}, {"label": "Regulatory and legal", "count": 4}, {"label": "Analyst action", "count": 3}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "49", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+5.2% over one week, -0.5% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "How Health Canada\u2019s Longer-Wear CGM Approval At DexCom (DXCM) Has Changed Its Investment Story"}], "updated_at": "2026-07-16T05:13:51.565085+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}